Orthogonal Analytical Methods to Elucidate How Low Levels of Residual Crystallinity in Posaconazole Amorphous Solid Dispersions Impact Phase Behavior during Release

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Crystal Growth & Design

• Publication date

  2023-12-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1021/acs.cgd.3c01147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers

  2023cited by this paper
• Phase Behavior and Crystallization Kinetics of a Poorly Water-Soluble Weakly Basic Drug as a Function of Supersaturation and Media Composition.

  2022cited by this paper
• Industry White Paper: Contemporary Opportunities and Challenges in Characterizing Crystallinity in Amorphous Solid Dispersions.

  2022cited by this paper
• Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization

  2021cited by this paper
• Laser diffraction as a powerful tool for amorphous solid dispersion screening and dissolution understanding.

  2021cited by this paper
• Amorphous Solid Dispersions Containing Residual Crystallinity: Influence of Seed Properties and Polymer Adsorption on Dissolution Performance.

  2020cited by this paper
• Application and Limitations of Thermogravimetric Analysis to Delineate the Hot Melt Extrusion Chemical Stability Processing Window.

  2020cited by this paper
• Assessing the impact of endogenously derived crystalline drug on the in vivo performance of amorphous formulations.

  2019cited by this paper
• Elucidating spray-dried dispersion dissolution mechanisms with focused beam reflectance measurement: contribution of polymer chemistry and particle properties to performance

  2019cited by this paper
• Absorptive dissolution testing: An improved approach to study the impact of residual crystallinity on the performance of amorphous formulations.

  2019cited by this paper
• Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media

  2019cited by this paper
• Dissolution of Indomethacin Crystals into a Polymer Melt: Role of Diffusion and Fragmentation

  2019cited by this paper
• Melt extrusion with poorly soluble drugs - An integrated review.

  2018cited by this paper
• Tailoring supersaturation from amorphous solid dispersions

  2018cited by this paper
• Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion

  2018cited by this paper
• Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption

  2018cited by this paper
• The application of temperature‐composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity

  2018cited by this paper
• Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport

  2018cited by this paper
• Effects of the Preparation Process on the Properties of Amorphous Solid Dispersions

  2017cited by this paper
• Investigating the Impact of Drug Crystallinity in Amorphous Tacrolimus Capsules on Pharmacokinetics and Bioequivalence Using Discriminatory In Vitro Dissolution Testing and Physiologically Based Pharmacokinetic Modeling and Simulation.

  2017cited by this paper
• Interrelationships Between Structure and the Properties of Amorphous Solids of Pharmaceutical Interest.

  2017cited by this paper
• Heating rate dependence of melting peak temperature examined by DSC of heat flux type

  2016cited by this paper
• pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs.

  2015cited by this paper
• Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds

  2015cited by this paper
• Determination of tacrolimus crystalline fraction in the commercial immediate release amorphous solid dispersion products by a standardized X-ray powder diffraction method with chemometrics.

  2014cited by this paper
• Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation.

  2013cited by this paper
• Recent advances in the monitoring, modelling and control of crystallization systems

  2013cited by this paper
• Hot melt extrusion for amorphous solid dispersions: temperature and moisture activated drug-polymer interactions for enhanced stability.

  2013cited by this paper
• Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders.

  2012cited by this paper
• Drug precipitation-permeation interplay: supersaturation in an absorptive environment.

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.

  2012cited by this paper
• Selective imaging of active pharmaceutical ingredients in powdered blends with common excipients utilizing two-photon excited ultraviolet-fluorescence and ultraviolet-second order nonlinear optical imaging of chiral crystals.

  2012cited by this paper
• Second-order nonlinear optical imaging of chiral crystals.

  2011cited by this paper
• Prediction of the thermal phase diagram of amorphous solid dispersions by Flory-Huggins theory.

  2011cited by this paper
• Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.

  2010cited by this paper
• In vitro monitoring of dissolution of an immediate release tablet by focused beam reflectance measurement.

  2010cited by this paper
• Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.

  2008cited by this paper
• Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048).

  2008cited by this paper
• Theoretical and Practical Approaches for Prediction of Drug–Polymer Miscibility and Solubility

  2006cited by this paper
• Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids.

  2006cited by this paper
• Molecular weight determination of hypromellose acetate succinate (HPMCAS) using size exclusion chromatography with a multi-angle laser light scattering detector.

  2004cited by this paper
• Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.

  2003cited by this paper
• Phase Transitions in Supersaturated Drug Solution

  2003cited by this paper
• Surface properties probed by second-harmonic and sum-frequency generation

  1989cited by this paper
• Melting Point Depression and Kinetic Effects of Cooling on Crystallization in Poly(vinylidene fluoride)-Poly(methyl methacrylate) Mixtures

  1975cited by this paper

• Chemistry and Ionization of HPMCAS Influences the Dissolution and Solution-Mediated Crystallization of Posaconazole Amorphous Solid Dispersions.

  2024cites this paper
• Computational Support to Explore Ternary Solid Dispersions of Challenging Drugs Using Coformer and Hydroxypropyl Cellulose

  2024cites this paper
• Professor Lynne Taylor: Scientist, Educator, and Adventurer.

  2024cites this paper